Preventative Trial of DFMO in Patients With High Risk Neuroblastoma in Remission
This study is currently recruiting participants.
Verified February 2014 by Spectrum Health Hospitals
Cancer Prevention Pharmaceuticals, Inc.
University of Arizona
University of Hawaii
University of Vermont
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
First received: April 24, 2012
Last updated: February 5, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||June 2020|
|Estimated Primary Completion Date:||June 2016 (Final data collection date for primary outcome measure)|